Literature DB >> 34409578

Age-related LRRK2 G2019S Mutation Impacts Microglial Dopaminergic Fiber Refinement and Synaptic Pruning Involved in Abnormal Behaviors.

Qiuyang Zhang1,2,3,4, Xiaojuan Cheng1,2,3,4, Wei Wu5, Siyu Yang1,2,3, Hanlin You1,2,3,4, Zucheng Ye5, Nan Liu1,3,4,6, Xiaochun Chen1,3,4, Xiaodong Pan7,8,9,10,11.   

Abstract

Mutations in the leucine-rich repeat kinase 2 (LRRK2) gene are the most frequent cause of autosomal dominant Parkinson's disease (PD), producing psychiatric and motor symptoms. We conducted this study to explore whether microglial dopaminergic (DAergic) fiber refinement and synaptic pruning are involved in the abnormal behavioral phenotypes of carriers of the LRRK2 G2019S mutation, by employing young and middle-aged PD model mice. The results revealed a characteristic late-onset hyperactivity and a progressive decline in the motor coordination of the LRRK2 G2019S mutation mice. LRRK2 G2019S mutation-induced aberrant microglial morphogenesis, with more branches and junctions per cell, resulted in excessive microglial refinement of dopaminergic (DAergic) fibers. Moreover, aberrant synaptic pruning distinctly impacted the prefrontal cortex (PFC) and dorsal striatum (DS), with significantly higher spine density in the PFC but the opposite effects in the DS region. Furthermore, LRRK2 G2019S mutation remodeled the inflammatory transcription landscape of microglia, rendering certain cerebral areas highly susceptible to microglial immune response. These findings indicate that LRRK2 G2019S mutation induces the production of inflammatory cytokines and mediates abnormal microglial morphogenesis and activity, resulting in abnormal phagocytosis, synaptic pruning and loss of DAergic fibers during aging, and, eventually, PD-related behavioral abnormalities.
© 2021. The Author(s), under exclusive licence to Springer Science+Business Media, LLC, part of Springer Nature.

Entities:  

Keywords:  Abnormal behaviors; DAergic fiber refinement; LRRK2 G2019S mutation; Microglia; Synaptic pruning

Mesh:

Substances:

Year:  2021        PMID: 34409578     DOI: 10.1007/s12031-021-01896-6

Source DB:  PubMed          Journal:  J Mol Neurosci        ISSN: 0895-8696            Impact factor:   3.444


  36 in total

1.  LRRK2 is involved in the IFN-gamma response and host response to pathogens.

Authors:  Agnès Gardet; Yair Benita; Chun Li; Bruce E Sands; Isabel Ballester; Christine Stevens; Joshua R Korzenik; John D Rioux; Mark J Daly; Ramnik J Xavier; Daniel K Podolsky
Journal:  J Immunol       Date:  2010-10-04       Impact factor: 5.422

2.  3D reconstruction of histological sections: Application to mammary gland tissue.

Authors:  Ignacio Arganda-Carreras; Rodrigo Fernández-González; Arrate Muñoz-Barrutia; Carlos Ortiz-De-Solorzano
Journal:  Microsc Res Tech       Date:  2010-10       Impact factor: 2.769

Review 3.  PSD95: A synaptic protein implicated in schizophrenia or autism?

Authors:  Austin A Coley; Wen-Jun Gao
Journal:  Prog Neuropsychopharmacol Biol Psychiatry       Date:  2017-11-21       Impact factor: 5.067

4.  A simple method to measure stride length as an index of nigrostriatal dysfunction in mice.

Authors:  Pierre O Fernagut; Elsa Diguet; Bertrand Labattu; François Tison
Journal:  J Neurosci Methods       Date:  2002-01-30       Impact factor: 2.390

5.  Leucine-rich repeat kinase-2 (LRRK2) modulates microglial phenotype and dopaminergic neurodegeneration.

Authors:  Zach Dwyer; Chris Rudyk; Ashley Thompson; Kyle Farmer; Barbara Fenner; Teresa Fortin; Alexa Derksen; Hongyu Sun; Shawn Hayley
Journal:  Neurobiol Aging       Date:  2020-02-27       Impact factor: 4.673

Review 6.  Parkinson's disease: Autoimmunity and neuroinflammation.

Authors:  Armando De Virgilio; Antonio Greco; Giovanni Fabbrini; Maurizio Inghilleri; Maria Ida Rizzo; Andrea Gallo; Michela Conte; Chiara Rosato; Mario Ciniglio Appiani; Marco de Vincentiis
Journal:  Autoimmun Rev       Date:  2016-08-04       Impact factor: 9.754

7.  (G2019S) LRRK2 causes early-phase dysfunction of SNpc dopaminergic neurons and impairment of corticostriatal long-term depression in the PD transgenic mouse.

Authors:  Jun-Shiao Chou; Chu-Yu Chen; Ying-Ling Chen; Yi-Hsin Weng; Tu-Hsueh Yeh; Chin-Song Lu; Ya-Ming Chang; Hung-Li Wang
Journal:  Neurobiol Dis       Date:  2014-05-14       Impact factor: 5.996

8.  Expression analysis of Lrrk1, Lrrk2 and Lrrk2 splice variants in mice.

Authors:  Florian Giesert; Andreas Hofmann; Alexander Bürger; Julia Zerle; Karina Kloos; Ulrich Hafen; Luise Ernst; Jingzhong Zhang; Daniela Maria Vogt-Weisenhorn; Wolfgang Wurst
Journal:  PLoS One       Date:  2013-05-10       Impact factor: 3.240

9.  LRRK2 G2019S mutation attenuates microglial motility by inhibiting focal adhesion kinase.

Authors:  Insup Choi; Beomsue Kim; Ji-Won Byun; Sung Hoon Baik; Yun Hyun Huh; Jong-Hyeon Kim; Inhee Mook-Jung; Woo Keun Song; Joo-Ho Shin; Hyemyung Seo; Young Ho Suh; Ilo Jou; Sang Myun Park; Ho Chul Kang; Eun-Hye Joe
Journal:  Nat Commun       Date:  2015-09-14       Impact factor: 14.919

10.  TNF-alpha-induced microglia activation requires miR-342: impact on NF-kB signaling and neurotoxicity.

Authors:  João Paulo Brás; Joana Bravo; Jaime Freitas; Mário Adolfo Barbosa; Susana Gomes Santos; Teresa Summavielle; Maria Inês Almeida
Journal:  Cell Death Dis       Date:  2020-06-02       Impact factor: 8.469

View more
  1 in total

1.  Age-Dependent Neuropsychiatric Symptoms in the NF-κB/c-Rel Knockout Mouse Model of Parkinson's Disease.

Authors:  Edoardo Parrella; Federico Del Gallo; Vanessa Porrini; Cristina Gussago; Marina Benarese; Paolo Francesco Fabene; Marina Pizzi
Journal:  Front Behav Neurosci       Date:  2022-03-11       Impact factor: 3.558

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.